VDS Pharma SRL
The score of VDS Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VDS Pharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 14 Apr 2026
- Year ended 30 Sep 2024filed on 11 Apr 2025
- Year ended 30 Sep 2023filed on 25 Apr 2024
- Year ended 30 Sep 2022filed on 24 Mar 2023
- Year ended 30 Sep 2021filed on 29 Apr 2022
VDS Pharma's financial analysis
- Solvency61.2%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VDS Pharma
VDS Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0597.740.922
- VAT number
- BE0597740922
- Peppol
- Registered · 0208:0597740922 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Feb 2015
- Registered office
- 1600 Sint-Pieters-Leeuw
- Latest accounts
- 2025 · filed on 14 Apr 2026
- Activity
- Activities of holding companies (NACE 64210)
VDS Pharma (SRL) has been based in Sint-Pieters-Leeuw since 2015, active in: activities of holding companies. For 2025, it reports a net profit of 74,668 € and equity of 502,844 €; its revenue is not published. Its solvency stands at 61.2%, above the median of its sector (55.6%).
Companies similar to VDS Pharma
Companies in the same business, of comparable size and area, outside its group.
- Hooyberghs Hans Activities of holding companies Mol · balance sheet 835,857 €
- Juvimmo Activities of holding companies Brasschaat · balance sheet 824,729 €
- Outsourcing Expertise Through Personal Solutions Activities of holding companies Hasselt · balance sheet 817,047 €
- BAETEN Project Management Activities of holding companies Ghent · balance sheet 816,995 €
- Lagae Activities of holding companies Temse · balance sheet 816,414 €
- SG Project Consult Activities of holding companies Aalter · balance sheet 814,100 €
- Degematt Activities of holding companies Wevelgem · balance sheet 836,380 €
- 5D Solutions Activities of holding companies Lummen · balance sheet 807,171 €
Frequently asked questions about VDS Pharma
What is the revenue of VDS Pharma?
VDS Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VDS Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0597740922 for VDS Pharma, if the company is VAT-registered. Its company number (CBE) is 0597.740.922.
Where is the registered office of VDS Pharma?
According to the CBE register, the registered office of VDS Pharma is in 1600 Sint-Pieters-Leeuw.
What is the equity of VDS Pharma?
At the close of the 2025 financial year, the equity of VDS Pharma amounts to 502,844 €, a solvency of 61.2% of total assets.
Who manages VDS Pharma?
The register lists 1 active mandates at VDS Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VDS Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →